合成葡萄糖合物疫苗的生产和特征
Aina Valenti1, Peter H Seeberger1, Oren Moscovitz2
1Max Planck Institute of Colloids and Interfaces, Potsdam, Germany.
Methods in molecular biology (Clifton, N.J.)
|April 23, 2025
概括
合成甘氨酸与载体蛋白的化学结合对于开发有效的碳水化合物疫苗至关重要. 这种方法增强了免疫反应,产生了针对癌症相关碳水化合物的高 afinity 抗体.
科学领域:
- 碳水化合物的化学成分
- 疫苗的研发工作正在进行中.
- 免疫学 免疫学 免疫学
背景情况:
- 聚糖蛋白结合对于改善疫苗设计中的甘氨酸的免疫性至关重要.
- 对未充电的碳水化合物的T细胞独立反应缺乏强大的抗体生产和记忆力.
- 载体蛋白如CRM197或破伤风毒素引起T细胞依赖的反应,导致高亲和抗体.
研究的目的:
- 描述一种用于制备合成甘氨酸结合物的常用策略.
- 详细介绍一项促进碳水化合物结合抗体开发的协议.
- 帮助开发针对癌症的向疗法.
主要方法:
- 合成甘氨酸与载体蛋白的化学结合,使用间隔器和链接器.
- 利用功能组,主要是氨基,将甘氨酸合到蛋白质氨酸残留物和N端.
- 合成葡萄糖合物制剂的详细方案.
主要成果:
- 建立了一种制造合成甘氨酸结合物的方法.
- 该协议促进了合成甘氨酸与载体蛋白的合.
- 旨在产生针对瘤相关碳水化合物抗原的抗体.
结论:
- 合成葡萄糖合物制剂是现代疫苗开发的一个关键策略.
- 该协议提供了一种创建基于碳水化合物的新型免疫疗法的方法.
- 该方法支持开发用于癌症治疗的抗体.
相关概念视频
Conjugated Proteins
18.1K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.1K
Protein Glycosylation
6.4K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
6.4K
Proteoglycans
3.8K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.8K
Hybridoma Technology
13.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.8K
Vaccinations
43.0K
Overview
43.0K
Cancer Vaccines
237
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
237


